BOLCATO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 593
EU - Europa 86
AS - Asia 34
AF - Africa 3
SA - Sud America 2
Totale 718
Nazione #
US - Stati Uniti d'America 593
IT - Italia 35
CN - Cina 27
FI - Finlandia 17
PL - Polonia 11
DE - Germania 6
GB - Regno Unito 5
SE - Svezia 5
IN - India 4
AR - Argentina 2
BE - Belgio 2
IE - Irlanda 2
MA - Marocco 2
NL - Olanda 2
VN - Vietnam 2
AT - Austria 1
EG - Egitto 1
PK - Pakistan 1
Totale 718
Città #
Fairfield 92
Chandler 68
Ashburn 57
Seattle 46
Houston 45
Woodbridge 39
Cambridge 38
Wilmington 26
San Diego 17
Helsinki 16
Medford 13
Princeton 13
Foligno 11
Warsaw 11
Ann Arbor 10
Padova 9
Beijing 8
Columbus 8
Des Moines 7
Ogden 7
Cagliari 6
Roxbury 6
Pune 4
Los Angeles 3
Can Tho 2
Condove 2
Cordoba 2
Dublin 2
Frederick 2
Limena 2
Nanjing 2
Ningbo 2
Acton 1
Bochum 1
Brentford 1
Casablanca 1
Changsha 1
Eggenstein-Leopoldshafen 1
Fontanelle 1
Groningen 1
Gujranwala 1
Hangzhou 1
Innsbruck 1
Khouribga 1
Lappeenranta 1
Leawood 1
London 1
Mattinata 1
Milan 1
Monmouth Junction 1
Nanchang 1
New Albany 1
Norwalk 1
Overpelt 1
Prescot 1
Selvazzano Dentro 1
Shanghai 1
Zhengzhou 1
Totale 602
Nome #
Can We Still Trust Docking Results? An Extension of the Applicability of DockBench on PDBbind Database 85
Revisiting the Allosteric Regulation of Sodium Cation on the Binding of Adenosine at the Human A2A Adenosine Receptor: Insights from Supervised Molecular Dynamics (SuMD) Simulations 80
Deciphering the Molecular Recognition Mechanism of Multidrug Resistance Staphylococcus aureus NorA Efflux Pump Using a Supervised Molecular Dynamics Approach 78
Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δinhibitors 61
A deep-learning approach toward rational molecular docking protocol selection 53
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1 delta 50
Combinare approcci tempo-dipendenti e tempo-indipendenti nella scoperta di farmaci 50
New insights into key determinants for adenosine 1 receptor antagonists selectivity using supervised molecular dynamics simulations 42
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332 42
Inspecting the Mechanism of Fragment Hits Binding on SARS‐CoV‐2 M pro by Using Supervised Molecular Dynamics (SuMD) Simulations 35
Shedding Light on the Molecular Recognition of Sub-Kilodalton Macrocyclic Peptides on Thrombin by Supervised Molecular Dynamics 35
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir 33
Comparing fragment binding posesprediction using HSP90 as a key study: When bound water makes the difference 32
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease Mpro 20
Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism? 18
Computational Strategies to Identify New Drug Candidates against Neuroinflammation 17
[1,2,4]Triazolo[1,5‐c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines 3
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors 2
Drugging the Undruggable Trypanosoma brucei Monothiol Glutaredoxin 1 1
Totale 737
Categoria #
all - tutte 4.060
article - articoli 3.938
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020109 0 4 6 7 12 6 12 13 24 12 9 4
2020/2021133 5 6 40 9 1 1 0 19 23 14 11 4
2021/2022180 4 3 8 9 9 10 21 23 49 6 5 33
2022/2023145 24 0 1 10 31 20 3 17 24 4 8 3
2023/2024170 6 36 20 7 32 13 24 15 12 5 0 0
Totale 737